Prescription Drugs Medicaid

Prescription Drugs Medicaid Archive

Clear Filters

… results in Prescription Drugs Medicaid.

May 2, 2022
NHeLP Comments on CMS Request for Information on Access to Coverage and Care in Medicaid & CHIP
Charly Gilfoil, Cat Duffy, Abigail Coursolle, Mara Youdelman, Wayne Turner, Jennifer Lav, Elizabeth Edwards, and David Machledt Comments
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (RFI) to develop and implement a comprehensive strategy to help ensure equitable access to Medicaid and the Children's Health Insurance Program (CHIP). In comments, NHeLP responds to the RFI questions on issues ranging from eligibility and…
Read more
April 14, 2022
NHeLP comments on Oregon’s application for renewal of the Oregon Health Plan § 1115(a) Demonstration Waiver for 2022-2027
Sarah Somers and Wayne Turner Comments
In public comments, NHeLP expresses support for Oregon's decision to abandon its waiver of EPSDT. However, NHeLP strongly opposes Oregon's proposal to exclude outpatient prescription drugs approved under the FDA's accelerated approval pathway. Denying Medicaid enrollees access to effective break-through therapies would harm people with serious or life-threatening medical…
Read more
April 12, 2022
NHeLP Comments on the Proposed Update to the CDC’s Opioid Prescribing Guidelines
Héctor Hernández-Delgado and Alexis Robles-Fradet Comments
In these comments to the Centers for Disease Control and Prevention (CDC), NHeLPs conveys its support for the CDC's proposal to update the 2016 Opioid Prescribing Guidelines. NHeLP's comments highlight the negative consequences the 2016 guidelines have had on access to medically necessary opioid medications for pain, particularly for…
Read more
April 8, 2022
More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs
Abigail Coursolle Issue Brief
Under federal law, state Medicaid programs are required to cover (with a few exceptions) outpatient prescription drugs for “medically accepted indications.” Medically accepted indications are both those that are included on the drug’s label by the FDA as part of the approval process, and certain “off-label” uses.Medicaid programs are…
Read more
February 11, 2022
NHeLP letter to HHS Sec. Becerra – Re: Advancing Health Equity Through Essential Health Benefits
Wayne Turner, Héctor Hernández-Delgado, and Fabiola De Liban Letter
The Affordable Care Act (ACA) established a comprehensive set of ten Essential Health Benefits (EHB) that most health plans must cover. However, regulations allowing states to define EHB through a benchmarking process have lead to inconsistent and inadequate coverage. In this letter to HHS Secretary Xavier Becerra, NHeLP urges…
Read more
February 4, 2022
Coverage of Over-the-Counter Drugs in Medicaid (Revised February 2022)
Abigail Coursolle and Liz McCaman Taylor Issue Brief, Fact Sheet
Drug coverage is an important facet of the Medicaid program. Although it is an optional benefit, all states cover outpatient prescription drugs in their Medicaid programs. States have significantly more leeway, however, in whether they cover over-the-counter (OTC) drugs. This Fact Sheet provides an overview of Medicaid rules for…
Read more

Prescription Drugs Medicaid Archive

Never miss a thing.

Subscribe today.

NHeLP Comments on CMS Request for Information on Access to Coverage and Care in Medicaid & CHIP

NHeLP comments on Oregon’s application for renewal of the Oregon Health Plan § 1115(a) Demonstration Waiver for 2022-2027

NHeLP Comments on the Proposed Update to the CDC’s Opioid Prescribing Guidelines

More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs

NHeLP letter to HHS Sec. Becerra – Re: Advancing Health Equity Through Essential Health Benefits

Coverage of Over-the-Counter Drugs in Medicaid (Revised February 2022)